Navigation Links
BioElectronics' ActiPatch Reduces Muscle Soreness in Runners
Date:5/7/2012

FREDERICK, Md., May 7, 2012 /PRNewswire/ -- BioElectronics Corporation (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the completion of a randomized, controlled trial on delayed muscle onset soreness using BIEL's ActiPatch® product.  ActiPatch uses pulsed electromagnetic field therapy to reduce pain, inflammation, and promote the healing of injured tissue.

A double blind, randomized, placebo controlled trial on delayed onset muscle soreness after marathon running found that ActiPatch® significantly reduces muscle soreness in the thighs in  runners, in the days after the completion of a marathon, compared to runners who used a placebo device. There was also a strong trend to increased running activity post marathon, which was significant on the first day after the marathon. This research study is now under peer review for publication, and the results will also be presented at EFORT (European Federation of National Associations of Orthopaedics and Traumatology) conference in Berlin, May 2012. The principle investigator leading the research was Dr. Rasmussen, Associate Professor Director of Research, Aarhus University Hospital, Aalborg Hospital, Denmark.

This study also confirms the results in the previous US muscle onset soreness study wherein ActiPatch® showed superior, and statistically significant pain relief compared to the OTC drug, acetaminophen. It has been forwarded to the FDA to support the Company's ActiPatch® application for relief of musculoskeletal pain. 

"We are delighted about the completion of this second randomized control trial on delayed muscle onset soreness," said Ian Rawe, Ph.D., BioElectronics Director of Clinical Research. "There are currently no interventions that can effectively alleviate muscle soreness, and certainly none that allow for quicker return to physical activity. These results suggest that BioElect
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioElectronics Announces Major Clinical Trials
2. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
3. BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date
4. YesDTC Holdings and BioElectronics Receive Japanese Regulatory Review Date
5. BioElectronics Corporation to Webcast, Live, at RetailInvestorConferences.com on October 6th
6. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
9. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
10. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015  BD (Becton, Dickinson and Company) (NYSE: ... company, today announced its participation in the White ... steps the company will take to help combat ... full range of expertise related to identification and ... information to electronic surveillance and prevention of health ...
(Date:6/2/2015)... 2015 Northstar Global Business Services, Inc. ... commercial advertisement, which it plans to use in ... company,s top selling product. The advertisement ... with television advertising. Previous ads focused on a ... version takes an entertainment-oriented path, and uses one ...
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ... meeting annuale della American Society of Clinical Oncology    ... multicentrico di fase 3 SAR3007, resi noti dal dipartimento ... hanno evidenziato un significativo miglioramento della sopravvivenza libera da ... ) rispetto al trattamento con dacarbazina in pazienti con ...
Breaking Medicine Technology:BD Participates in White House Forum on Antibiotic Stewardship 2BD Participates in White House Forum on Antibiotic Stewardship 3Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... 2011 Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader ... the year ended December 31, 2010. Financial ... Ended December 31, 2009: Total revenues were ... the U.S. decreased 16% to $4.53 million from $5.28 million. ...
... 4, 2011 MonoSol Rx, the developers of PharmFilm® ... pharmaceutical film products, today announced that it has been ... Patent and Trademark Office (USPTO). The patent provides intellectual ... preparation along with the incorporation of specific drugs and ...
Cached Medicine Technology:Milestone Scientific Announces 2010 Year End Results 2Milestone Scientific Announces 2010 Year End Results 3Milestone Scientific Announces 2010 Year End Results 4Milestone Scientific Announces 2010 Year End Results 5Milestone Scientific Announces 2010 Year End Results 6MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes 2MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes 3
(Date:6/2/2015)... June 02, 2015 CRN International has been ... Platform to Employment , a Connecticut state program that takes ... and place them at appropriate companies. , Platform to Employment ... with the Connecticut Department of Labor. CRN, a 40-year-old radio ... the program, is being recognized for its “hard work and ...
(Date:6/2/2015)... COLUMBIA, Md. (PRWEB) June 02, 2015 ... of its LCMS-8060 triple quadrupole mass spectrometer. The ... series, the LCMS-8060 combines Shimadzu’s proprietary ultrafast technologies ... unparalleled combination results in outstanding data quality and ... and routine applications. , The LCMS-8060 features new ...
(Date:6/2/2015)... Zambia (PRWEB) June 02, 2015 ... businesses, today opened a new seed warehouse and office ... and meet farmer demand for both local and export ... , “Zambia could emerge as the breadbasket for ... said Worede Woldemariam, East and South Central Africa senior ...
(Date:6/2/2015)... 2015 PhishLine, LLC today announced ... Swenson Drive, Suite 125 in Waukesha, Wisconsin 53186. ... new base of operations for PhishLine’s current corporate ... growth. , Mark Chapman, Founder and President, commented ... as enterprise customers adopt our market leading service ...
(Date:6/2/2015)... a popular online store selling celebrity inspired fashion products, ... dresses. The company carries more than 1000 styles of ... a wide variety of summer events like wedding and ... quality trendy special occasion dresses and accessories. ... and cotton. Their products feature a wide range of ...
Breaking Medicine News(10 mins):Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2
... 2012 Testosterone, the primary male sex hormone, appears ... its effects have remained unclear. Nicole Carrier and Mohamed ... to elucidate these mechanisms. They,ve discovered that a ... in memory formation and regulation of stress responses, plays ...
... Society (ERS) and the European Centre for Disease Prevention ... Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards ... ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) ... in the EU/EEA in 2010 clearly showing that TB ...
... in men with prostate cancer before prostatectomy helped to reduce ... cancer, according to the results of a phase II study. ... at the Princess Margaret Hospital, University Health Network in Toronto, ... 2012, held here March 31 - April 4. Metformin ...
... FRIDAY, March 30 (HealthDay News) -- Cold conditions may affect ... research studies, a new study suggests. Researchers from the ... drugs tested on mice that were housed in chilly temperatures ... because being cold triggers changes in mice,s immune function and ...
... FRIDAY, March 30 (HealthDay News) -- While unseasonably warm weather ... thrilled with the early arrival of spring. Arriving along ... hay-fever sufferers sneezing at least a few weeks sooner than ... season starting early, but the pollen counts are breaking records. ...
... , FRIDAY, March 30 (HealthDay News) -- The declining ... a specialty is cause for concern because there,s already ... downward trend has occurred for the past six years, ... Medical schools need to provide more information and training ...
Cached Medicine News:Health News:Exploring the antidepressant effects of testosterone 2Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Metformin appeared to slow prostate cancer growth 2Health News:For Better Mouse Studies, Let Them Nest 2Health News:Warm Weather Triggers Early Allergy Season 2Health News:Warm Weather Triggers Early Allergy Season 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: